Revelation Biosciences, Inc., (REVB) Social Stream
REVELATION BIOSCIENCES INC (REVB) Price Targets From Analysts
Use the tables below to see what analysts covering REVELATION BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-17 | 1 | $12 | $12 | $12 | $0.47 | 2453.19% |
| 2022-05-16 | 1 | $9 | $9 | $9 | $0.47 | 1814.89% |
| 2022-10-07 | 1 | $174.825 | $174.825 | $174.825 | $0.47 | 37096.81% |
| 2023-05-22 | 1 | $15 | $15 | $15 | $0.47 | 3091.49% |
| 2023-11-14 | 1 | $15 | $7.9 | $11.45 | $0.47 | 2336.17% |
Price Target Last Issued October 7, 2022
The Trend in the Analyst Price Target
REVB's average price target has moved down $3.55 over the prior 39 weeks.
REVB reports an average of 1,149.84% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-14 | 1 | 15 | 15.0 | 15.00 | 2.700 | 455.56% |
| 2023-05-22 | 1 | 15 | 15.0 | 15.00 | 1.190 | 1160.5% |
| 2023-06-22 | 1 | 15 | 7.9 | 11.45 | 1.040 | 1000.96% |
| 2023-08-14 | 1 | 15 | 7.9 | 11.45 | 0.731 | 1466.35% |
| 2023-11-14 | 1 | 15 | 7.9 | 11.45 | 0.615 | 1761.79% |
REVB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
REVB's average broker recommendation rating improved by 0 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- REVB has a greater number of analysts covering the stock than just about none of of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, REVELATION BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 593.26% of them.
- REVB has a lower variance in analysts' estimates than 25.55% of stocks in the micro market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, REVELATION BIOSCIENCES INC's average analyst price target is higher than 176.69% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to REVELATION BIOSCIENCES INC are VIRI, BPTS, and VRPX.
View All Top Stocks by Price Target
Make investment decisions regarding REVB using the data that counts. Try POWR Ratings for free.